FDA warns about dental problems associated with buprenorphine medications
نویسندگان
چکیده
In early January 2022, FDA released a Drug Safety Communication surrounding dental problems following use of buccal and sublingual buprenorphine products for the treatment pain opioid disorder. The warning comes after reports problems, including tooth decay, cavities, oral infections, loss teeth, in patients using buprenorphine, regardless their history. Buprenorphine variety formulations, Subutex (sublingual tablets); Suboxone (combination product with naloxone available both films Sublocade (extended-release subcutaneous injection); Belbuca (buccal film); Butrans (transdermal patch). Initially approved disorder 2002 as tablet, were later pain. (buprenorphine transdermal patches) are currently only FDA-approved management severe enough to require daily, around-the-clock, long-term which alternative options inadequate. Opioid agonist medications, can reduce saliva production mouth, according FDA. Reduced lead mentioned previously. While or injectable formulations have risk dry these not statement. said they will be requiring new on added prescribing information patient medication guides all dissolvable containing products. This is required patch formulations. With this warning, recommends prescribers, dentists, pharmacists do part educating health. Prescribers should prepared ask about health history, last time was seen by dentist. Also, may also recommendations dentists whom refer patients. addition informing proper hygiene techniques, counsel gently rinse teeth gums water, then swallow once has completely dissolved. They need wait at least one hour taking dose before brush teeth. Some steps that take optimum decay include twice daily brushing, regular flossing, drinking water throughout day, routine checkups. Substance Abuse Mental Health Services Association “[urge] providers weigh lifesaving benefits identified making decisions starting ongoing buprenorphine.” states when combined counseling other behavioral therapies, commonly most effective way treat
منابع مشابه
UK bans, Health Canada warns about antidepressants.
Six months after the UK banned antidepressant drugs for children, Health Canada has issued a warning that using 7 of the medications may make patients worse. Patients of all ages taking flu-voxamine (Luvox), paroxetine (Paxil), sertraline (Zoloft), mir-tazapine (Remeron), fluoxetine (Prozac) and citalopram (Celexa), as well as those taking bupropion as an antidepressant (Wellbutrin) or smoking ...
متن کاملFDA-approved medications that impair human spermatogenesis
We herein provide an overview of the single-ingredient U.S. Food and Drug Administration (FDA)-approved drugs that affect human spermatogenesis, potentially resulting in a negative impact on male fertility. To provide this information, we performed an in-depth search of DailyMed, the official website for FDA-approved drug labels. Not surprisingly, hormone-based agents were found to be the drugs...
متن کاملMethadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
While street drugs appear unlikely to alter the metabolism of antiretroviral (ARV) medications, several ARVs may induce or inhibit metabolism of various street drugs. However, research on these interactions is limited. Case reports have documented life-threatening overdoses of ecstasy and gamma-hydroxybutyrate after starting ritonavir, an ARV that inhibits several metabolic enzymes. For opioid ...
متن کاملSystematic Review: FDA-Approved Prescription Medications for Adults With Constipation.
Constipation is a common, often chronic, gastrointestinal disorder that can negatively impact the lives of those it affects and can be difficult to treat satisfactorily. The objective of this systematic review is to identify and analyze the available published literature on US Food and Drug Administration-approved prescription therapies for adults with constipation (episodic and chronic) and to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacy Today
سال: 2022
ISSN: ['1042-0991', '2773-0735']
DOI: https://doi.org/10.1016/j.ptdy.2022.03.021